Today: 11 June 2026
Browse Category

Apple 18 December 2025 - 14 January 2026

Apple stock treads water as Google Gemini enters Siri, with earnings next on deck

Apple stock treads water as Google Gemini enters Siri, with earnings next on deck

Apple shares hovered near $261 early Wednesday after announcing a multiyear deal to use Google’s Gemini AI in Siri. The move puts OpenAI’s ChatGPT in a secondary role and expands Google’s reach across Apple’s two billion devices. Investors are watching for impact on Apple’s AI strategy ahead of its Jan. 29 earnings report. Industry data showed Apple led 2025 smartphone shipments but faces risks in 2026.
14 January 2026
····
Apple stock slips after-hours as Creator Studio launch and Google Gemini tie-up reset the AI pitch

Apple stock slips after-hours as Creator Studio launch and Google Gemini tie-up reset the AI pitch

Apple shares slipped 0.25% to $259.61 after hours Tuesday following the announcement of “Apple Creator Studio,” a $12.99/month creative software bundle launching Jan. 28. The rollout comes as investors weigh Apple’s new AI partnership with Google’s Gemini and await the company’s earnings report on Jan. 29.
13 January 2026
····
Google stock (GOOG) pops on Apple’s Gemini-powered Siri deal as Alphabet brushes $4 trillion

Google stock (GOOG) pops on Apple’s Gemini-powered Siri deal as Alphabet brushes $4 trillion

Alphabet’s Class C shares rose 1.1% to $332.73 in after-hours trading after Apple announced a multi-year deal to use Google’s Gemini models in a revamped Siri. Alphabet’s market value briefly touched $4 trillion earlier in the day. The agreement deepens Google’s AI presence in Apple devices and draws regulatory scrutiny. Investors await Alphabet’s Feb. 4 earnings for updates on AI spending and cloud growth.
12 January 2026
··
Apple stock slips as India antitrust fine risk resurfaces and JPMorgan takes over Apple Card

Apple stock slips as India antitrust fine risk resurfaces and JPMorgan takes over Apple Card

Apple shares fell 0.7% to $258.58 after hours Thursday, valuing the company at about $3 trillion. India’s antitrust watchdog told a court that Apple could face fines up to $38 billion in an App Store case, with a hearing set for Jan. 27. JPMorgan will replace Goldman Sachs as Apple Card issuer, moving over $20 billion in balances. The Nasdaq slipped as big tech stocks declined.
8 January 2026
···
Apple stock slips today as Apple Card shifts to JPMorgan, payrolls and earnings loom

Apple stock slips today as Apple Card shifts to JPMorgan, payrolls and earnings loom

Apple shares fell 0.8% to $260.33 in early Thursday trading after Alphabet surpassed its market value for the first time since 2019. Apple and JPMorgan said Chase will take over as Apple Card issuer in about 24 months, pending regulatory approval. Goldman expects the deal to add 46 cents per share to its Q4 2025 earnings. Investors await Friday’s U.S. jobs report and Apple’s Jan. 29 earnings call.
8 January 2026
····
Apple stock today: AAPL starts 2026 on a softer note as valuation talk returns, Vision Pro in focus

Apple stock today: AAPL starts 2026 on a softer note as valuation talk returns, Vision Pro in focus

Apple shares fell 0.3% to $271.01 Friday as Raymond James resumed coverage with a “Market Perform” rating, citing valuation. The company confirmed Ben Borders as principal accounting officer in an SEC filing. Reports flagged Vision Pro production cutbacks after weak sales. Investors await Monday’s ISM manufacturing data and Apple’s late-January earnings.
3 January 2026
··
Apple Stock Today: AAPL trades near $274 as China iPhone data, Apple Watch ruling, and new Wall Street targets shape the 2026 outlook

Apple Stock Today: AAPL trades near $274 as China iPhone data, Apple Watch ruling, and new Wall Street targets shape the 2026 outlook

Apple shares traded around $274.50 midday Friday, up 0.25%, after data showed foreign-branded phone shipments in China jumped 128% in November. U.S. markets remained open for a full session, with thin trading and major indexes near record highs. Apple’s market value held near $4 trillion. The S&P 500 hit an intraday record before easing.
26 December 2025
···
Apple Stock (AAPL) News on Dec. 25, 2025: China iPhone Shipments Surge, AI “Siri 2.0” Bets Grow, and Wall Street’s 2026 Price Targets

Apple Stock (AAPL) News on Dec. 25, 2025: China iPhone Shipments Surge, AI “Siri 2.0” Bets Grow, and Wall Street’s 2026 Price Targets

Apple shares closed Dec. 24 at about $273.81, putting market value near $4.05 trillion. U.S. exchanges are shut for Christmas. New China data showed foreign-branded phone shipments, including iPhones, jumped 128% year-over-year in November, fueling debate over Apple’s demand outlook in its key market.
25 December 2025
···
Apple Stock (AAPL) After-Hours Today (Dec. 22, 2025): Italy Antitrust Fine, China Signals, and What to Watch Before Tuesday’s Market Open

Apple Stock (AAPL) After-Hours Today (Dec. 22, 2025): Italy Antitrust Fine, China Signals, and What to Watch Before Tuesday’s Market Open

Apple shares closed down 0.99% at $270.97 Monday, underperforming the S&P 500, which rose 0.64%. Italy’s antitrust authority fined Apple and two divisions €98.6 million over App Store and privacy practices; Apple said it will appeal. After-hours, the stock slipped another 0.11% to $270.66. Trading volume reached about 36.1 million shares.
23 December 2025
··
Apple Stock (AAPL) After Hours Today, Dec. 18, 2025: What Moved Shares After the Bell—and What to Watch Before Friday’s Open

Apple Stock (AAPL) After Hours Today, Dec. 18, 2025: What Moved Shares After the Bell—and What to Watch Before Friday’s Open

Apple shares closed Thursday at $272.19, up 0.13%, then slipped to $271.18 in after-hours trading. The move followed news that Apple will allow third-party app stores and alternative payments on iPhones in Japan to comply with new competition rules. Investors also weighed updated Wall Street targets tied to Apple’s 2026 AI plans and fresh U.S. inflation data.
18 December 2025
··
1 2 3 4 5 … 10

Stock Market Today

  • SGX Securities Turnover Jumps 70% in May, Market Capitalisation Tops Southeast Asia
    June 11, 2026, 5:44 PM EDT. Singapore Exchange (SGX) saw a 70% year-on-year rise in securities market turnover to S$45.8 billion in May, marking Southeast Asia's largest market capitalisation. Daily average securities value increased 79% to S$2.4 billion, the highest since 2007. Derivatives volume expanded 20% YoY with a 27% rise in daily average contracts. The Straits Times Index reached a record high of 5,072 on May 19, fueled by banking and tech sectors. Institutional and retail investors boosted small- and mid-cap stocks, with retail participation hitting a 13-year high. Capital raising surged with JustCo Holdings' Mainboard listing and secondary placements raising S$316 million. SGX commodities and FX futures also recorded volume gains, highlighting broad market strength across asset classes.

Latest articles

Bradesco Shares Rise, BBDC4 and BBD ADRs Track Brazil Market Recovery

Bradesco Shares Rise, BBDC4 and BBD ADRs Track Brazil Market Recovery

11 June 2026
Bradesco’s preferred shares jumped to R$17.67 and U.S. ADRs to $3.44 with heavy volume as Brazil’s Ibovespa surged 1.71%, spotlighting the lender after reporting a 16.1% year-over-year rise in recurring net income to R$6.811 billion in 1Q26; board and executive insiders sold non-voting shares, while the controlling group’s stake remained unchanged.
Bank of Nova Scotia Hits 52-Week High; TSX Bounces Back

Bank of Nova Scotia Hits 52-Week High; TSX Bounces Back

11 June 2026
Bank of Nova Scotia surged to a 52-week high, closing up 1.24% at C$115.27 in Toronto after announcing expanded AI adoption across its workforce and higher Q2 earnings, while the S&P/TSX Composite jumped 1.5% as financials rallied and trading volume soared above average.
Moderna Gains Almost 8% With Nasdaq Recovery; Cancer Vaccine Pipeline Still a Key Focus

Moderna Gains Almost 8% With Nasdaq Recovery; Cancer Vaccine Pipeline Still a Key Focus

11 June 2026
Moderna surged 7.94% to $49.64 as U.S. stocks rebounded sharply, with investors eyeing its mRNA cancer-vaccine pipeline after a UK trial authorization; Wall Street’s average analyst rating remains “Hold” with a $43.30 target, and BofA raised its price target to $34 citing norovirus prospects, while Moderna reported Q1 revenue of $389 million and a $1.3 billion net loss.
Go toTop